Multiple Myeloma Market: Advancements in CAR-T Cell and Bispecific...

added blog Other

2025-05-28 06:31:34 -

Multiple Myeloma Market: Advancements in CAR-T Cell and Bispecific Antibody Therapies

A new market analysis highlights significant growth for the global multiple myeloma market. Valued at USD 23.20 billion in 2023 and estimated to reach USD 25.17 billion in 2024, the market is projected to grow to USD 44.82 billion by 2031, exhibiting a robust Compound Annual Growth Rate (CAGR) of 8.59% during the forecast period. This strong expansion is primarily driven by the increasing...

0 Comments 0 Shares 64 Views 0 Reviews